Medical Condition News

RSS

PolyMedix plans PMX-60056 Phase 2 clinical trial in interventional cardiology

PolyMedix, Inc., a biotechnology company focused on developing new therapeutic drugs to treat infectious diseases and acute cardiovascular disorders, has announced plans for a Phase 2 clinical trial of PMX-60056 in interventional cardiology, and the establishment of a focused Heptagonist Clinical Advisory Board (CAB). PMX-60056 is a synthetic small-molecule designed to reverse the anticoagulant activity of heparin and low molecular weight heparins (LMWH).

21 Oct 2010

IDEV includes two stents to SUPERA product line for treating patients with peripheral vascular disease

IDEV Technologies, Incorporated (IDEV), an innovative leader in the development and commercialization of minimally invasive medical technologies, today announced another step in the implementation of its strategy to expand its product line for treating patients with peripheral vascular disease with the addition of two longer stents to its SUPERA product line.

21 Oct 2010

Cerenis raises €10 million in second close of Series C financing

Cerenis Therapeutics, a biopharmaceutical company specializing in the research and development of novel therapies based on HDL to treat cardiovascular and other metabolic diseases, announced today it has raised a further €10 million in a second close of its Series C financing. This takes the total funds raised in the Series C to €50 million and the total equity investment raised to date by the Company to €117 million.

21 Oct 2010

Study finds online activities does not effect long-term psychological health

After the campus shootings at Virginia Tech in 2007 and Northern Illinois University in 2008, hundreds of affected students turned to social media websites to share their grief and search for solace. A new study of these students found that their online activities neither helped nor harmed their long-term psychological health.

21 Oct 2010

ISCTM to develop solutions for CNS clinical trial methodology

The International Society for CNS Clinical Trials and Methodology (ISCTM) met recently to develop solutions to challenges facing CNS clinical trial methodology.

21 Oct 2010

Major companies phase out BPA from food and beverage packaging

Major brand name companies including Hain Celestial, H.J. Heinz, ConAgra, and General Mills are taking a leadership role in responding to consumer market shifts as awareness about health hazards of the endocrine disrupting chemical bisphenol A (BPA) in food can linings rises.

21 Oct 2010

Researcher creates novel theory about chronic depression

Chronic depression is an adaptive, reparative neurobiological process gone wrong, say two University of California, San Diego School of Medicine researchers, positing in a new theory that the debilitating mental state originates from more ancient mechanisms used by the body to deal with physical injury, such as pain, tissue repair and convalescent behavior.

21 Oct 2010

New data from ESHO/EORTC STBSG Phase III clinical study of hyperthermia

BSD Medical Corporation announced publication in Internal Medicine News Digital Network of new data from the ESHO/EORTC Soft Tissue and Bone Sarcoma Group (STBSG) Phase III clinical study of hyperthermia.

21 Oct 2010

Bonati Spine Institute supports National Breast Cancer Awareness

The Bonati Spine Institute, the leading center for the patented Bonati Spine Procedures for minimally invasive laser spine surgery, is a strong supporter of National Breast Cancer Awareness.

21 Oct 2010

$OptiNose reports positive results from study of fluticasone delivered by novel device in refractory CRS$

OptiNose reports positive results from study of fluticasone delivered by novel device in refractory CRS

Today OptiNose Inc. announced the positive results of a study evaluating the efficacy of fluticasone when delivered by the Company's novel bi-directional technology in patients with refractory chronic rhinosinusitis (CRS). The results of the study have been published in an article in the September issue of Rhinology.

21 Oct 2010

Endocrine Society's statement clarifies association between hormone therapy and breast cancer risk

Richard J. Santen, MD, lead author of The Endocrine Society's Scientific Statement on menopausal hormone therapy, can provide clarity on the association of hormone therapy and increased risk of breast cancer as reported in an article published this week in The Journal of the American Medical Association (JAMA)

21 Oct 2010

Tel Aviv University research links obsessive-compulsive disorder to common childhood illness

A common infection in children, strep throat can lead to problems with a child's heart, joints or brain if left untreated. And when the brain is involved, motor and mental functioning may be compromised, leading to syndromes such as attention deficit disorder and obsessive-compulsive disorder (OCD).

21 Oct 2010

National Staging Initiative to standardize cancer stage information across Canada

Canadians can expect to benefit from more targeted investments in cancer screening and treatment as a result of a first-of-its-kind initiative that is standardizing the collection of cancer stage information across Canada. The initiative marks a change that cancer experts have wanted for more than 20 years, and that will help cancer system decision-makers to target areas of greatest need in cancer control.

21 Oct 2010

Study shows virtual colonoscopy can improve colorectal cancer screening rates

Providing computed tomography colonography (CTC) otherwise known as virtual colonoscopy as an alternative to conventional colonoscopy could improve colorectal cancer (CRC) screening rates, according to a study in the November issue of the American Journal of Roentgenology

21 Oct 2010

Lubricin reduces wear to bone cartilage

A team of researchers in North Carolina has discovered that lubricin, a synovial fluid glycoprotein, reduces wear to bone cartilage. This result, which has implications for the treatment of sufferers of osteoarthritis, will be presented today at the AVS 57th International Symposium & Exhibition, taking place this week at the Albuquerque Convention Center in New Mexico.

21 Oct 2010

SO2 emission raise health concerns

Kilauea Volcano on Hawaii's big island has been erupting on its east rift since 1983. But, in March 2008, an additional eruption vent opened at the volcano's summit, resulting in about triple the amount of sulfur dioxide gas (SO2) emissions drifting to the local community of Ka'u, raising health concerns over the risks associated with exposure to "vog," as the islanders refer to this volcanic air pollution.

21 Oct 2010

Team effort involving providers and parents needed to address rise in pediatric obesity rates

Over the last few decades, the dramatic rise in pediatric obesity rates has emerged as a public health threat requiring urgent attention. The responsibility of identifying and treating eating and weight-related problems early in children and adolescents falls to health care providers and other professionals who work with the child, according to Professor Denise Wilfley and colleagues from the Department of Psychiatry at Washington University School of Medicine in the US. Furthermore, the key to successful treatment is a team effort involving providers and parents.

21 Oct 2010

Automatic behaviors are stored in frontal cortex

Some people may excel at riding a bike, tying a tie, or playing the piano, but those same people may find it difficult to explain or teach those skills to someone else. These motor skills are learned in one part of the brain, whereas classroom instruction and information read in a book are acquired in another area of the brain, explained F. Gregory Ashby, professor and chair of UC Santa Barbara's Department of Psychology. This second area of learning is the frontal cortex the area immediately behind the forehead -- where executive function is located.

21 Oct 2010

Researcher hopes to provide effective medication for Parkinson's disease

The side effects of the standard medication for Parkinson's disease have long been a preoccupation of brain researchers. Now Daniella Rylander has presented new findings in a recently defended PhD thesis at Lund University that provide hope of more effective medication for those who suffer from the nerve cell disease.

21 Oct 2010

UW Medicine patient receives implantable device for vestibular problems

A University of Washington Medical Center patient on Thursday, Oct. 21, will be the world's first recipient of a device that aims to quell the disabling vertigo associated with Meniere's disease.

21 Oct 2010